Indeed, mice heterozygous for aSMase or treated with an aSMase inhibitor are resistant to hepatic fibrosis induced by bile duct ligation or carbon tetrachloride (CCl4) [124,129]. The gene discussed is SMPD1; the disease is Hepatic fibrosis.